ETOPOPHOS is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Etoposide Phosphate.
Product ID | 0015-3404_23c5d977-f8be-4f5b-b810-9a0ec0866925 |
NDC | 0015-3404 |
Product Type | Human Prescription Drug |
Proprietary Name | ETOPOPHOS |
Generic Name | Etoposide Phosphate |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2009-06-01 |
Marketing Category | NDA / NDA |
Application Number | NDA020457 |
Labeler Name | E.R. Squibb & Sons, L.L.C. |
Substance Name | ETOPOSIDE PHOSPHATE |
Active Ingredient Strength | 100 mg/1 |
Pharm Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2009-06-01 |
Marketing End Date | 2021-04-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020457 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-06-01 |
Marketing End Date | 2021-04-30 |
Ingredient | Strength |
---|---|
ETOPOSIDE PHOSPHATE | 100 mg/1 |
NDC | Brand Name | Generic Name |
---|---|---|
0015-3404 | ETOPOPHOS | etoposide phosphate |
61269-410 | ETOPOPHOS | etoposide phosphate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ETOPOPHOS 74179774 1757537 Live/Registered |
CHEPLAPHARM ARZNEIMITTEL GMBH 1991-06-25 |